1.
Long-term Safety and Efficacy of Difelikefalin in Subjects With Chronic Kidney Disease–Associated Pruritus: Analysis From KALM-1 and KALM-2. J of Skin. 2021;5(6):s75. doi:10.25251/skin.5.supp.75